Identification of Tubulin as the Molecular Target of Proapoptotic Pyrrolo-1,5-benzoxazepines
Authors:
- Lisa M. GreeneLGLisa M. Greene
- Suzanne CloonanSCSuzanne Cloonan
- Margaret M. Mc GeeMGMargaret M. Mc Gee
- Valeria OnnisVOValeria Onnis
- Giuseppe CampianiGCGiuseppe Campiani
- Caterina FattorussoCFCaterina Fattorusso
- Mark LawlerMLMark Lawler
- D. Clive WilliamsDWD. Clive Williams
- Daniela M. ZistererDZDaniela M. Zisterer
- 1 July 2006
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 70 (1) , 60-70
Abstract
We have demonstrated previously that certain members of a series of novel pyrrolo-1,5-benzoxazepine (PBOX) compounds potently induce apoptosis in a variety of human chemotherapy-resistant cancer cell lines and in primary ex vivo material derived from cancer patients. A better understanding of the molecular mechanisms underlying the apoptotic effects of these PBOX compounds is essential to their development as antineoplastic therapeutic agents. This study sought to test the hypothesis that proapoptotic PBOX compounds target the microtubules. We show that a representative proapoptotic PBOX compound, PBOX-6, induces apoptosis in both the MCF-7 and K562 cell lines. An accumulation of cells in G2/M precedes apoptosis in response to PBOX-6. PBOX-6 induces prometaphase arrest and causes an accumulation of cyclin B1 levels and activation of cyclin B1/CDK1 kinase in a manner similar to that of two representative antimicrotubule agents, nocodazole and paclitaxel. Indirect immunofluorescence demonstrates that both PBOX-6 and another pro-apoptotic PBOX compound, PBOX-15, cause microtubule depolymerization in MCF-7 cells. They also inhibit the assembly of purified tubulin in vitro, whereas a nonapoptotic PBOX compound (PBOX-21) has no effect on either the cellular microtubule network or on the assembly of purified tubulin. This suggests that the molecular target of the pro-apoptotic PBOX compounds is tubulin. PBOX-6 does not bind to either the vinblastine or the colchicine binding site on tubulin, suggesting that it binds to an as-yet-uncharacterised novel site on tubulin. The ability of PBOX-6 to bind tubulin and cause microtubule depolymerization confirms it as a novel candidate for antineoplastic therapy.Keywords
This publication has 34 references indexed in Scilit:
- Selective Induction of Apoptosis by the Pyrrolo-1,5-benzoxazepine 7-[{Dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia Cells Occurs via the c-Jun NH2-Terminal Kinase-Dependent Phosphorylation and Inactivation of Bcl-2 and Bcl-XLThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Salvinal, a Novel Microtubule Inhibitor Isolated from Salvia miltiorrhizae Bunge (Danshen), with Antimitotic Activity in Multidrug-Sensitive and -Resistant Human Tumor CellsMolecular Pharmacology, 2004
- Paclitaxel-resistant Human Ovarian Cancer Cells Undergo c-Jun NH2-terminal Kinase-mediated Apoptosis in Response to NoscapineJournal of Biological Chemistry, 2002
- Activation of the c-Jun N-terminal Kinase (JNK) Signaling Pathway Is Essential during PBOX-6-induced Apoptosis in Chronic Myelogenous Leukemia (CML) CellsJournal of Biological Chemistry, 2002
- The interaction of the B-ring of colchicine with α-tubulin: a novel footprinting approach 1 1Edited by M. F. MoodyJournal of Molecular Biology, 2000
- Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cellsOncogene, 1999
- Suppression of Microtubule Dynamics by Binding of Cemadotin to Tubulin: Possible Mechanism for Its Antitumor ActionBiochemistry, 1998
- Identification of Cysteine 354 of β-Tubulin as Part of the Binding Site for the A Ring of ColchicineJournal of Biological Chemistry, 1996
- Mitosis in transitionCell, 1994
- Interaction of anthelmintic benzimidazoles and benzimidazole derivatives with bovine brain tubulinBiochimica et Biophysica Acta (BBA) - General Subjects, 1978